As of 2025-05-19, the Intrinsic Value of Fermenta Biotech Ltd (506414.BO) is 40.80 INR. This 506414.BO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 303.15 INR, the upside of Fermenta Biotech Ltd is -86.50%.
The range of the Intrinsic Value is 25.12 - 69.66 INR
Based on its market price of 303.15 INR and our intrinsic valuation, Fermenta Biotech Ltd (506414.BO) is overvalued by 86.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 25.12 - 69.66 | 40.80 | -86.5% |
| DCF (Growth 10y) | 47.23 - 105.99 | 68.10 | -77.5% |
| DCF (EBITDA 5y) | 128.14 - 165.42 | 147.77 | -51.3% |
| DCF (EBITDA 10y) | 115.10 - 167.77 | 140.70 | -53.6% |
| Fair Value | 60.90 - 60.90 | 60.90 | -79.91% |
| P/E | 183.69 - 230.71 | 204.94 | -32.4% |
| EV/EBITDA | 100.73 - 307.38 | 199.65 | -34.1% |
| EPV | 92.66 - 127.78 | 110.22 | -63.6% |
| DDM - Stable | 67.69 - 160.70 | 114.19 | -62.3% |
| DDM - Multi | 33.96 - 63.24 | 44.26 | -85.4% |
| Market Cap (mil) | 8,842.89 |
| Beta | 0.35 |
| Outstanding shares (mil) | 29.17 |
| Enterprise Value (mil) | 9,721.54 |
| Market risk premium | 8.31% |
| Cost of Equity | 13.71% |
| Cost of Debt | 8.07% |
| WACC | 12.70% |